Abstract
The sex hormones and corticosteroids influence neuroelectrophysiology, neuroanatomy, and cognition [1–3] through their interaction with a variety of brain structures, particularly the hippocampus [2, 4]. Normative levels of estrogen and testosterone as well as homeostatic levels of corticosteroids are required for optimal cognitive functioning. The present review will focus on the neuropsychological sequelae of conditions resulting from elevated or insufficient levels of the primary sex hormones and corticosteroids as well as post-treatment neuropsychological response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Janowsky JS. Thinking with your gonads: testosterone and cognitive. Trends Cog Sci. 2006;10(2):77–82.
Spencer JL, Waters EM, Romeo RD, et al. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol. 2008;29(2):219–37.
Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J Psychiatr Res. 2001;35:127–45.
Verghese J, Kusansky G, Katz MJ, et al. Cognitive performance in surgical menopausal women on estrogen. Neurology. 2000;55:872–4.
Brett KM, Madan JH. Use of posthormonal hormone replacement therapy estimates from a nationally representative cohort study. Am J Epidemiol. 1997;145:536–45.
Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Aging Study. J Clin Endocrinol Metab. 2001;86:724–31.
Ross J, Roeltgen D, Zinn A. Cognition and the sex chromosomes: studies in Turner Syndrome. Horm Res. 2006;65(1):47–56.
Geschwind DH, Boone KB, Miller BL, Swerdloff RS. Neurobehavioral phenotype of Klinefelter syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:107–16.
Mandoki MW, Sumner GS, Hoffman RP, Riconda DL. A review of Klinefelter’s syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1991;30(2):167–72.
Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 1990;10:1286–91.
Adams MM, Shah RA, Janssen WG, Morrison JH. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc Natl Acad Sci USA. 2001;98:8071–6.
Hao J, Janssen WG, Tang Y, et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol. 2003;465(4):540–50.
Woolley CS, Wentzel HJ, Schwartzkroin PA. Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol. 1996;373:108–17.
Cordoba Montoya DA, Carrer HF. Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. Brain Res. 1997;778:430–8.
Markowska AL, Savonenko AV. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci. 2002;22:10985–95.
Savonenko AV, Markowska AL. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience. 2003;19:821–30.
Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.
Sherwin BB. Estrogen and cognitive aging in women. Neuroscience. 2006;138:1021–6.
Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol. 1994;83(6):979–83.
Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav. 1995;29(3):312–21.
Maki PM, Zonderman AB, Resnick SM. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry. 2001;158(2):227–33.
Robinson D, Friedman L, Marcus R, et al. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc. 1994;42(9):919–22.
Resnick SM, Maki PM, Golski S, et al. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav. 1998;34(2):171–82.
Schmidt R, Fazekas F, Reinhart B, et al. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Gerontol Soc. 1996;44:1307–13.
Hogervorst E, Boshuisen M, Riedel W, et al. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology. 1999;24:43–68.
Steffans DC, Norton MC, Plassman BL, et al. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc. 1999;47:1171–5.
Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA. 1993;269:2637–41.
Grodstein F, Chen J, Pollen DA, et al. Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Gerontol Soc. 2000;48:746–52.
Jacobs DM, Tag M-X, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 1998;50:368–73.
Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen–progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame project. Arch Intern Med. 2000;160:1641–9.
Szklo M, Cerhan J, Diez-Roux AV, et al. Estrogen replacement therapy and cognitive functioning in the artherosclerotic risk in communities (ARIC) study. Am J Epidemiol. 1996;144:1048–57.
Resnick SM, Metter EJ, Zonderman AB. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology. 1997;49(6):1491–7.
Matthews K, Cauley J, Yaffe K, Zmuda J. Estrogen replacement therapy and cognitive decline in older community women. J Am Gerontol Soc. 1999;47:518–23.
Yaffe K, Haan M, Byers A, et al. Estrogen use, ApoE, and cognitive decline. Neurology. 2000;54:1949–53.
Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57.
Phillips SM, Sherwin BB. Effects on estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992;17:485–95.
Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology. 2000;149:129–39.
Binder EF, Schectman KB, Birge SJ, et al. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas. 2001;38:137–46.
Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 1991;78:459–66.
Goebel JA, Birge SJ, Price SC, et al. Estrogen replacement therapy and postural stability in the elderly. Am J Otol. 1995;16(4):470–4.
Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci. 2000;12(3):407–14.
Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197–202.
LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systemic review and meta-analysis. J Am Med Dir Assoc. 2001;285:1489–99.
Hogervorst E, Yaffee K, Richards M, Huppert F. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev Issue. 2008;3:1–9.
Craig MC, Maki PM, Murphy DGM. The women’s health initiative memory study: findings and implications for treatment. Lancet Neurol. 2005;4:190–4.
Maki PM. Hormone Therapy and cognitive function: is there a critical period for benefit? Neuroscience. 2006;138:1027–30.
Resnick SM, Coker LH, Maki PM, et al. The Women’s Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials. 2004;1:440–50.
Zandi PP, Carlson MC, Plassman ML, et al. Hormone replacement therapy and incidence of Alzheimer’s disease is older women: Te Cache County Study. JAMA. 2002;288:2123–9.
Bender B, Linden M, Robinson A. Neuropsychological impairment in 42 adolescents with sex chromosome abnormalities. Am J Genet B Neuropsychiatr Genet. 1993;48:169–73.
Haberecht MF, Menon V, Warsofsky IS, et al. Functional neuroanatomy of visuo-spatial working memory in Turner syndrome. Hum Brain Mapp. 2001;14:96–107.
McCauley EM, Kay T, Ito J, Treder R. The Turner syndrome: cognitive deficits, affective discrimination, and behavior problems. Child Dev. 1987;58:464–73.
Romans SM, Stefanatos G, Roeltgen DP, et al. Transition to young adulthood in Ullrich–Turner syndrome: neurodevelopmental changes. Am J Med Genet A. 1998;79:140–9.
Zinn AR, Roeltgen D, Stefanatos G, et al. A Turner syndrome neurocognitive phenotype maps to Xp22.3. Behav Brain Funct. 2007;21:3–24.
Tsoubi T, Nielsen J, Nagayama I. Turner’s syndrome: a qualitative and quantitative analysis of EEG background activity. Hum Genet. 1998;78:206–15.
Bender B, Puck M, Salbenblatt J, Robinson A. Cognitive development of unselected girls with complete and partial X monosomy. Pediatrics. 1984;73:175–82.
Ross JL, Stefanatos G, Roeltgen D, et al. Ullrich–Turner syndrome: neurodevelopmental changes from childhood through adolescence. Am J Med Genet. 1995;58:74–82.
Cornoldi C, Marconi F, Vecchi T. Visuospatial working memory in Turner’s syndrome. Brain Cogn. 2001;46(1–2):90–4.
Ross J, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:135–41.
Ross JL, Kushner H, Roeltgen DP. Developmental changes in motor function in girls with Turner Syndrome. Pediatr Neurol. 1996;15:317–32.
Kesler SR, Menon V, Reiss AI. Neurofunctional differences associated with arithmetic processing in Turner Syndrome. Cereb Cortex. 2006;16:849–56.
Kesler SR, Haberecht MF, Menon V, et al. Functional neuroanatomy of spatial orientation processing in Turner Syndrome. Cereb Cortex. 2004;14(2):174–80.
Russell HF, Wallis D, Mazzocco MMM, et al. Increasing prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006;31(9):945–55.
Nijhuis van der Sanden MWG, Eling PATM, Otten BJ. A review of neuropsychological and motor studies in Turner syndrome. Neurosci Biobehav Rev. 2003;27:329–38.
Pennington B, Bender B, Puck M, et al. Learning disabilities in children with sex chromosome anomalies. Child Dev. 1982;53:1182–92.
Waber DP. Neuropsychological aspects of Turner’s syndrome. Dev Med Child Neurol. 1979;21:58–70.
Rovet J, Netley C, Bailey J, et al. Intelligence and achievement in children with extra X aneuploidy: a longitudinal perspective. Am Med Genet B Neuropsychiatr Genet. 1995;60:356–63.
Cornoldi C, De Beni R, Giusberti F, Massironi M. Memory and imagery: A visual trace is not a mental image. In: Conway’s MA, Gatherode SE, Cornoldi C, editors. Theories of memory. Hove, UK: Psychology Press. Volume 2, pp 187–210.
Lezak MD, Howieson DB, Loring DW. Neuro-psychological assessment. 4th ed. New York, NY: Oxford University Press; 2004.
Hampson E. Estrogen-related variations in human spatial and articulatory-skills. Psychoneuroendocrinology. 1990;15:97–111.
Ross JL, Roeltgen D, Feuillan P, et al. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner’s syndrome. J Clin Endocrinol Metab. 1998;83(9):3198–204.
Ross JL, Roeltgen D, Stefanatos GA, et al. Androgen-responsive aspects of cognition in girls with Turner syndrome. J Clin Endocrinol Metab. 2003;88(1):292–6.
Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J. Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status. Clin Endocrinol. 1999;50:791–800.
Shute VJ, Pellegrino JW, Hubert L, Reynolds RW. The relationship between androgen levels and human spatial ability. Bull Psychon Soc. 1983;21:465–8.
Tirassa P, Thilbin I, Angren G, et al. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor in male rat brain. J Neurosci Res. 1997;47:198–207.
Morse JK, DeKosky ST, Scheff SW. Neurotrophic effects of steroids on lesion-induced growth in the hippocampus-II. Exp Neurol. 1992;118:47–52.
Leranth C, Petnehazy O, MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003;23(5):1588–92.
Leranth C, Prange-Kiel J, Frick K, Horvath TL. Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb Cortex. 2004;14:503–10.
Kritzer ME, McLaughlin PJ, Smirlis T, Robinson JK. Gonadectomy impairs T-maze acquisition in adult male rats. Horm Behav. 2001;39:167–74.
Edinger KL, Frye CA. Testosterone’s analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci. 2004;118(6):1352–64.
Kritzer ME, Brewer A, Montalmant F, et al. Effects of gonadectomy on performance in operant tasks measuring prefrontal cortical function in adult male rats. Horm Behav. 2007;51(2):183–94.
Kawakami J, Cowan JE, Elkin EP, et al. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer. 2006;106(8):1708–14.
Salminen EK, Portin RI, Koskinen A, et al. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res. 2004;10:7575–82.
Cherrier M, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol. 2003;170:1808–11.
Almeida OP, Waterreus A, Spry N, et al. One year follow-up study of the associations between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29:1071–81.
Bussiere JR, Beer TM, Neiss MB, Janowsky JS. Androgen deprivation impairs memory in older men. Behav Neurosci. 2005;119(6):429–1437.
Cherrier MM, Craft S, Matsumoto AH. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl. 2003;24(4):568–76.
Moffat SD, Zonderman AB, Metter EJ, et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87:5001–7.
Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc. 1999;47:1289–93.
Alexander GM, Swerdloff RS, Wang C, et al. Androgen-behavior correlations in hypogonadal men and eugonadal men: II. Cognitive abilities. Horm Behav. 1998;33:85–94.
Cherrier MM, Matsumoto AM, Amory JK, et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psycho-neuroendocrinology. 2007;32:72–9.
Gandy S, Almeida OP, Fonte J, et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285:2195–6.
Moffat SD, Zonderman AB, Metter EJ, Kawas C, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):170–1.
Chu L, Tam S, Lee PWH, et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol. 2008;68(4):589–98.
Kenny AM, Fabregas G, Song C, et al. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol. 2004;59A(1):75–8.
Lu PH, Masterman DA, Mulnard R, et al. Effects of testosterone on cognition and mod in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63:177–85.
Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter’s syndrome. Lancet. 2004;364:273–83.
Bender B, Fry E, Pennington B, et al. Speech and language development in 41 children with sex chromosome anomalies. Pediatrics. 1983;71:262–7.
Bender BG, Puck MH, Salbenblatt JA, Robinson A. Dyslexia in 47, XXY boys identified at birth. Behav Genet. 1986;16:343–54.
Bender B, Linden M, Robinson A. Verbal and spatial processing efficiency in 32 children with sex chromosome abnormalities. Pediatr Res. 1989;25:577–9.
Itti E, Gonzalo ITG, Pawlikowska-Haddal A, et al. The structural brain correlates of cognitive deficits in adults with Klinefelter’s syndrome. J Clin Endocrinol Metab. 2006;91(4):1423–7.
Netley C, Rovet J. Hemispheric lateralization in 47, XXY Klinefelter’s syndrome boys. Brain Cogn. 1984;3(1):10–18.
Ross JL, Roeltgen DP, Benecke R, et al. Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A. 2008;146A(6):708–19.
Rovet J, Netley C, Bailey J, Keenan M, Stewart D. Intelligence and achievement in children with extra X aneuploidy: a longitudinal perspective. Am J Med Genet. 1995;60:356–63.
Rovet J, Netley C, Neenan M. The psychoeducational profile of boys with Klinefelter syndrome. J Learn Disabil. 1996;29:180–96.
Temple CM, Sanfilippo PM. Executive skills in Klinefelter’s syndrome. Neuropsychologia. 2003;41:1547–59.
Patwardhan AJ, Brown WE, Bender BG, et al. Reduced size of the amygdale in individuals with 47, XXY and 47, XXX karyotypes. Am J Med Genet. 2002;114(1):93–8.
Patwardhan AJ, Eliez S, Bender B, et al. Brain morphology in Klinefelter syndrome: extra X chromosome and testosterone supplementation. Neurology. 2000;54(12):2218–28.
Warwick MM, Doody GA, Lawrie SM, et al. Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies. J Neurol Neurosurg Psychiatry. 1999;66(5):628–32.
Geschwind DH, Gregg J, Boone K, et al. Klinefelter’s syndrome as a model of anomalous cerebral laterality: testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. Dev Genet. 1998;23(3):215–29.
Geidd JN, Clasen LS, Wallace GL, et al. XXY (Klinefelter syndrome): a pediatric quantitative brain magnetic resonance imaging case–control study. Pediatrics. 2007;119:232–40.
Waltzer S, Bashir AS, Silbert AR. Cognitive and behavioral factors in the learning disabilities of 47, XXY and 47, XYY boys. Birth Defects. 1991;26:45–58.
Robinson A, Bender BG, Borelli JB. Sex chromosome aneuploidy: prospective and longitudinal studies. Birth defects: original article series. 1986;22:23–71.
Ratcliffe S. Long-term outcome in children of sex chromosome abnormalities. Arch Dis Child. 1999;80:192–5.
Leonard MF, Sparrow S. Prospective study of development of children with sex abnormalities: New Haven study IV. Adolescence. In: Ratcliffe SG, Paul N, editors. Birth defects: original article series, vol. 22(3). New York, NY: Alan R. Liss, Inc.; 1986. p. 221–49.
Van Rijn S, Aleman A, Swaab H. What it is said versus how it is said: comprehension of affective prosody in men with Klinefelter (47, XXY) syndrome. J Int Neuropsychol Soc. 2007;13:1065–70.
Fales CL, Knowlton BJ, Holyoak K, et al. Working memory and relational reasoning in Klinefelter syndrome. J Int Neuropsychol. 2003;9:839–46.
Boone KB, Swerdloff RS, Miller BL. Neuropsychological profiles of adults with Klinefelter syndrome. J Int Neuropsychol Soc. 2001;7:446–56.
Stewart DA, Bailey JD, Netley CT, Park E. Growth, development, and behavioral outcome from mid-adolescence to adulthood in subjects with chromosome aneuploidy: the Toronto Study. Birth Defects. 1991;26:131–88.
Tytherleigh MY, Vedhara K, Lightman SL. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison’s disease. Psychoneuroendocrinology. 2004;29:712–23.
Sapolsky R, Krey L, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuronal number: implications for aging. J Neurosci. 1985;5:1222–7.
Sapolsky R, Krey L, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7:284–301.
Woolley CS, Gould R, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990;531:225–31.
Wantabe Y, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of the adult hippocampal pyramidal neurons. Brain Res. 1990;531:225–31.
Bodnoff SR, Humphreys AG, Lehman JC, et al. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-age rats. J Neurosci. 1995;15:61–9.
Kerr DS, Campbell LW, Applegate MD, et al. Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci. 1991;11:1316–24.
DeLeon MJ, Rusinek H, McRae T, de Santi S, et al. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer’s Disease. J Clin Endocrinol Metab. 1997;82:3251–9.
Wolkowitz OM, Reus M, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry. 1990;147(10):1297–303.
Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairment in declarative memory performance in adults humans. J Neurosci. 1994;14(4):2047–53.
Newcomer JW, Sella H, Melson AK. Decreased memory performance in health humans induced by stress-level cortisol treatment. Arch Gen Psychiatry. 1999;56:527–33.
Schmidt LA, Fox NA, Goldberg MC, et al. Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology. 1999;24:461–83.
Kirschbaum C, Wolf OT, May M, et al. Stress-and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 1996;58(17):1475–83.
Lupien S, Gillin CJ, Hauger RL. Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose–response study in humans. Behav Neurosci. 1999;113(3):420–30.
Young AH, Sahakian BJ, Robbins TW. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology. 1999;145:260–6.
Hsu FC, Garside MJ, Massey AE, et al. Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers. Psychopharmacology. 2003;167:431–42.
Naber D, Sand P, Heigl B. Psychological and neuropsychological effects of 8-days’ corticosteroid treatment. A prospective study. Psychoneuroendocrinology. 1996;21:25–31.
Het S, Ramlow G, Wolf OT. A meta-analytic review of the effects of acute cortisol administration on human memory. Psychoneuroendocrinology. 2005;30:771–84.
Wolf OT, Convit A, McHugh PF, et al. Cortisol differentially affects memory in young and elderly men. Behav Neurosci. 2001;115:1002–11.
Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593–602.
Simmons NE, Do HM, Lipper MH, Laws ER Jr. Cerebral atrophy in Cushing’s disease. Surg Neurol. 2000;53:72–6.
Starkman MN, Giordani B, Berent S, et al. Elevated cortisol levels in Cushing’s Disease are associated with cognitive decrements. Psychosom Med. 2001;63:985–93.
Starkman MN, Giordani B, Gebarski SS, Schteingart DE. Improvement in learning associated with increase in hippocampal formation volume. Biol Psychiatry. 2003;53:233–8.
Hook J, Giordani B, Schteingart DE, et al. Patterns of cognitive change over time and relationship to age following successful treatment of Cushing’s disease. J Int Neuropsychol Soc. 2007;13:21–9.
Forget H, Lacroix A, Somma M, et al. Cognitive decline in patients with Cushing’s syndrome. J Int Neuropsychol Soc. 2000;6:20–9.
Dorn LD, Burgess ES, Dubbert B, et al. Psychopathology in patients with endogenous Cushing’s syndrome: “atypical” or melancholic features. Clin Endocrinol. 1995;43:433–42.
Bourdeau I, Bard C, Noel B, et al. Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab. 2002;87:1949–54.
Porter RJ, Bourke C, Gallagher P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust NZ J Psychiatry. 2007;41:115–28.
Grillon C, Smith K, Haynos A, Nieman LK. Deficits in hippocampus-mediated Pavlovian conditioning in endogenous hypercortisolism. Biol Psychiatry. 2004;56:837–43.
Starkman MN, Giordani B, Gebarski SS, et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry. 1999;46:1595–602.
Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55:1–9.
Nieman LK, Chanco Turner ML. Addison’s disease. Clin Dermatol. 2006;24:276–80.
Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335:1206–12.
Thomsen AF, Kvist TK, Andersen PK, Kessing LV. The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology. 2006;31:614–22.
Anglin RE, Rosebush PI, Mazurek MF. The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci. 2006;18:450–59.
Mizoguchi K, Ishige A, Takeda S, et al. Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci. 2004;23:5492–9.
Oitzl MS, De Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci. 1992;106:62–71.
Otte C, Moritz S, Yassouridis A, et al. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress, hormones, and cognition. Neuropsychopharmacology. 2007;32:232–8.
Acknowledgment
This work is supported in part by NIH grant DK70917, awarded to the third author. The opinions and views expressed herein are those of the authors and do not reflect those of the NIDDK.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Greene, M.M., Maher, K., Holmes, C.S. (2010). Neuropsychological Functioning of Endocrinology Disorders: Gonadotropic Hormones and Corticosteroids. In: Armstrong, C., Morrow, L. (eds) Handbook of Medical Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1364-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1364-7_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1363-0
Online ISBN: 978-1-4419-1364-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)